Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | TYR | P14679 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15603766 | 0.90 | ALDH1A1 (0.38) | ALDH1A1TSHRCA2POLBTYR | |
| SCHEMBL17239684 | 0.79 | TSHR (0.37) | TSHR | |
| SCHEMBL17239678 | 0.77 | GABRA1 (0.39) | POLB | |
| SCHEMBL17239660 | 0.74 | ALDH1A1 (0.44) | ALDH1A1CA2 | |
| SCHEMBL17239666 | 0.74 | HSPA5 (0.31) | — | |
| SCHEMBL20591137 | 0.73 | ACHE (0.41) | ALDH1A1 | |
| SCHEMBL1743625 | 0.71 | CYP3A4 (0.38) | ALDH1A1TSHR | |
| SCHEMBL1304876 | 0.71 | CYP3A4 (0.38) | ALDH1A1TSHR | |
| SCHEMBL16694111 | 0.71 | ALDH1A1 (0.33) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL20591109 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2871198-B1 | METHOD FOR PRODUCING AROMATIC COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2017-06-14 | — | — | EP | disclosed |
| US-9453103-B2 | Method for producing aromatic compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-09-27 | — | — | US | disclosed |
| US-20150322199-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150322199-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND | PAH, DDC, DDT | ALDH1A1 2296/4885TSHR 3555/4885CA2 1064/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.